Additionally, patients initiated with a short acting insulin regimen as a component of premixed insulin need to be highly vigilant to recognize the symptoms of hypoglycemia, and self-management to the monitoring of blood glucose levels. This evidence concerns the gene INS and Hypoglycemia.